Journal articles

1. Dowie MJ, Bradshaw HB, Howard ML, Nicholson LF, Faull RL, Hannan AJ, Glass M. Altered CB1 receptor and endocannabinoid level precede motor symptom onset in a transgenic mouse model of Huntington's disease.  Neuroscience, 163(1): 456-65, 2009
2. O'Carroll SJ, Mitchell MD, Faenza I, Cocco L and Gilmour RS. (2009). Nuclear PLC Beta 1 is required for 3T3-L1 adipocyte differentiation and regulates expression of the Cyclin D3-cdk4 complex. Cellular Signalling 10.1016/j.cellsig.2009.02.002.
3. C.R. Green, L.F.B. Nicholson.  Interrupting the inflammatory cycle in chronic diseases - Do gap junctions provide the answer? Cell Biology International, 32, p1578-1583, 2008
4. H.V. Danesh-Meyer, R. Huang, L.F.B. Nicholson, C.R. Green.  Connexin43 antisense oligonucleotide treatment down-regulates the inflammatory response in an in vitro interphase organotypic culture model of optic nerve ischemia, Journal of Clinical Neuroscience, 15, p1253-1263, 2008
5. Bhalla A, Stone PR, Liddell, H, O'Carroll S, Kearn C, Glass M and Chamley L. (2008). Nuclear localisation of the endocannabinoid metabolizing enzyme fatty acid amide hydrolase (FAAH) in invasive trophoblasts and an association with recurrent miscarriage. Placenta. Accepted for press.
6. S.J. O'Carroll, M.Alkadhi, L.F.B. Nicholson, C.R. Green. Connexin43 Mimetic Peptides Reduce Swelling, Astrogliosis and Neuronal Cell Death After Spinal Cord Injury, Cell Communication and Adhesion. 15(1), 27-42, 2008.
7. S. Shaikh, L.F.B. Nicholson. AGEs induce in vitro cross-linking of $ -synuclein and accelerate the process of intracellular inclusion body formation. Journal of Neuroscience Research. 86(9), 2071-2082. 2008.
8. I. Chevyreva, R.L.M. Faull, C.R. Green, L.F.B. Nicholson. Assessing RNA Quality in Postmortem Human Brain Tissue. Experimental and Molecular Pathology, 84, 71-77, 2008.
9. Dragunow M, Cameron R, Narayan P and O'Carroll S. (2007). Image-based highthroughput quantification of cellular fat accumulation. Journal of Biomolecular Screening 12(7):999-1005.
10. Lim JH, Gibbons HM, O'Carroll SJ, Narayan PJ, Faull RLM and Dragunow M. (2007). Extracellular signal-regulated kinase involvement in human astrocyte migration. Brain Research 1164:1-13.
11. A.K. Lai, W.L. Hou, D.J. Verdon, L.F.B. Nicholson, P.M. Barling. The distribution of the growth factors FGF-2 and VEGF, and their receptors, in growing red deer antler. Tissue & Cell, 39, 35-46, 2007.
12. Lipski J, Wan CK, Bai JZ, Pi R, Li D, Donnelly, D. (2007) Neuroprotective potential of ceftriaxone in in vitro models of stroke. Neuroscience 146(2):617-629.
13. Lind CR, Gray CW, Pearson AG, Cameron RE, O'Carroll SJ, Narayan PJ, Lim J, Dragunow M. (2006). The mitogen-activated/extracellular signal-regulated kinase kinase 1/2 inhibitor U0126 induces glial fibrillary acidic protein expression and reduces the proliferation and migration of C6 glioma cells. Neuroscience 141:1925-33.
14. Dragunow M, Greenwood JM, Cameron RE, Narayan PJ, O’Carroll SJ, Pearson AG, Gibbons HM. (2006). Valproic acid induces caspase 3-mediated apoptosis in microglial cells. Neuroscience 140:1149-1152.
15. Helliwell RJ, Keelan JA, Marvin KW, Adams L, Chang MC, Anand A, Sato TA, O'Carroll S, Chaiworapongsa T, Romero RJ, Mitchell MD. (2006). Gestational age-dependent upregulation of prostaglandin D synthase (PGDS) and production of PGDS-derived antiinflammatory prostaglandins in human placenta. Journal of Clinical Endocrinology and Metabolism 91:597-606.
16. S. Shaikh, L.F.B. Nicholson. Optimization of Tet-on system for inducible expression of RAGE. Journal of Biomolecular Techniques, 17, (4), p283-292, 2006.
17. L. Ma, H. Ostrovsky, G. Miles, J. Lipski, G.D. Funk and L.F.B. Nicholson. Differential expression of group 1 metabotropic receptors in human motoneurons at low and high risk of degeneration in ALS. Neuroscience, 143, (1), 95-104, 2006.
18. P.M. Barling, A.K.W. Lai and L.F.B. Nicholson. The distribution of EGF and its receptor in growing red deer antler. Cell Biology International, 29, (3), p229-236, 2005. 
19. Shaikh S, Bloomfield FH, Oliver MH, Bauer MK, Gilmour RS, Harding J., Amniotic IGF-I supplementation of growth restricted fetal sheep alters IGF-I and IGF-I receptor type I mRNA and protein levels in Placental and fetal tissues. J Endocrinology, 2005, 186, 145-55.
20. Dean J, Fraser M, Shelling AN, Bennet L, Shaikh S, Gunn AJ, Ontogeny of AMPA and NMDA receptor gene expression in the developing sheep white matter and cerebral cortex. Mol Brain Research. 2005, 139 (2): 242-50.
21. Li Ma and Louise F.B. Nicholson. Expression of RAGE in Huntington's Disease Caudate Nucleus. Brain Research, 1018,10-17, 2004.

Conference proceedings

1. Davidson J, Green CR, Bennet L, Nicholson LFB, O'Carroll S, Gunn AJ. Stopping the spread: Connexin hemichannels in hypoxic-ischemic brain injury. Meeting of the Fetal Neonatal Physiological Society. Maastricht, The Netherlands. 22-25 June 2008.
2. O'Carroll SJ, Green CR and Nicholson LFB. A role for connexin43 in the spread of damage after spinal cord injury. International Gap Junction Conference, Elsinore, Denmark. 12 – 17 July 2007.
3. Yoon J, O'Carroll SJ, Green CR and Nicholson LFB. The role of Connexin43 gap junctions in lesion spread during epilepsy. International Gap Junction Conference, Elsinore, Denmark. 12 – 17 July 2007.
4. O'Carroll SJ, Green CR and Nicholson LFB. Connexin mimetic peptide reduces swelling after spinal cord injury. 7th IBRO World Congress of Neuroscience, Melbourne, Australia. 12 – 17 July 2007.
5. Yoon J, O'Carroll SJ, Green CR and Nicholson LFB. Gap junctions in neurological diseases. 7th IBRO World Congress of Neuroscience, Melbourne, Australia. 12 – 17 July 2007.
6. Shaikh, S, Nicholson LFB. 'AGEs induce in vitro cross-linking of a-synuclein and accelerate the process of intracellular Lewy body formation', 7th IBRO (International Brain Research Organisation) World Congress of Neuroscience, Melbourne, Australia, 12-17 July, 2007.
7. Shaikh S, Hamilton TM, Nicholson LFB. 'Are Connexins Important in Parkinson’s Disease?', IBAGS IX-9th Triennial Meeting of the International Basal Ganglia Society, Hotel Zuiderduin, Egmond aan Zee, Netherlands, September 2-6, 2007.
8. Hamilton TM, Nicholson LFB, Shaikh, S. 'Connexin43 Localisation Is Altered In The Substantia Nigra Of Parkinson,s Disease Brains', Australasian Winter Conference on Brain Research (AWCBR), Queenstown, 25-29 August, 2007.
9. Perera AY, Nicholson LFB, Shaikh, S. 'Mechanisms of microglial activation by AGEs', Healthex, University of Auckland, 8th September, 2007.
10. Lim, JH, Faull RL, Gibbons, HM, Narayan, PJ, O'Carroll SJ, Dragunow, M. Modelling human glial scars in vitro. Annual Society for Neuroscience Meeting, Atlanta, Georgia. 14 – 18 October 2006
11. Dragunow M, Cameron R, Narayan P, O'Carroll S. High content screening of fat accumulation. High-Content Analysis 2006: High-content cellular assays for compound screening and pathway analysis. San Francisco, USA. 31 January – 3 February 2006.
12. Joanne Davidson, Colin Green, Louise Nicholson, Sherly George, Justin Dean, Carolina Hawranek, Simon O'Carroll, Guido Wassink, Laura Bennet, Alistair Jan Gunn. Connexin 43 gap junction and hemichannel expression following cerebral ischemia in near-term fetal sheep. NZ Medical Sciences Congress, Rotorua, New Zealand. 28 November – 1 December 2006.
13. O'Carroll SJ, Ma L., Dragunow MD, Green CR and Nicholson LFB. The role of connexins in neuronal-astroglial differentiation. 25th Annual Meeting of the Australian Neuroscience Society, 30 January – 2 February 2005, Perth, Australia.